BSGM RSI Chart
Last 7 days
-2.8%
Last 30 days
87.7%
Last 90 days
-37.2%
Trailing 12 Months
-88.8%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 219.0K | 152.0K | 85.0K | 18.0K |
2022 | 402.3K | 363.5K | 324.8K | 286.0K |
2021 | 0 | 0 | 0 | 441.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 01, 2024 | hrkac frederick | acquired | - | - | 500,000 | - |
Nov 30, 2023 | londoner kenneth l | acquired | - | - | 219,700 | chief executive officer |
Nov 30, 2023 | fleming gray | acquired | - | - | 131,900 | chief commercial officer |
Nov 30, 2023 | sieckhaus john | acquired | - | - | 92,300 | chief operating officer |
Aug 15, 2023 | weild iv david | acquired | - | - | 16,000 | - |
Aug 15, 2023 | barry james j | acquired | - | - | 12,000 | - |
Aug 15, 2023 | klein james l | acquired | - | - | 16,000 | - |
Aug 15, 2023 | foley donald e | acquired | - | - | 16,000 | - |
Aug 15, 2023 | hrkac frederick | acquired | - | - | 16,000 | - |
Aug 15, 2023 | gallagher patrick joseph | acquired | - | - | 12,000 | - |
Which funds bought or sold BSGM recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 25, 2024 | SIMPLEX TRADING, LLC | sold off | -100 | - | - | -% |
Apr 25, 2024 | SIMPLEX TRADING, LLC | new | - | 1,000 | 1,000 | -% |
Apr 24, 2024 | Hartford Financial Management Inc. | sold off | -100 | -475 | - | -% |
Apr 23, 2024 | Sugarloaf Wealth Management, LLC | unchanged | - | -409 | 66.00 | -% |
Apr 22, 2024 | PFG Investments, LLC | sold off | -100 | -74,860 | - | -% |
Apr 22, 2024 | PFG Investments, LLC | new | - | 70,163 | 70,163 | -% |
Apr 18, 2024 | SeaCrest Wealth Management, LLC | sold off | -100 | -4,050 | - | -% |
Apr 18, 2024 | SteelPeak Wealth, LLC | sold off | -100 | -6,650 | - | -% |
Apr 18, 2024 | Aspire Private Capital, LLC | sold off | -100 | -380 | - | -% |
Apr 18, 2024 | Aspire Private Capital, LLC | new | - | 132 | 132 | -% |
Unveiling BioSig Technologies Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to BioSig Technologies Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 186.5B | 40.1B | 32.59 | 4.65 | ||||
BDX | 66.9B | 19.5B | 53.25 | 3.43 | ||||
ALGN | 23.2B | 3.9B | 52.14 | 6.01 | ||||
BAX | 20.4B | 14.8B | 7.67 | 1.38 | ||||
MID-CAP | ||||||||
ATR | 9.5B | 3.5B | 30.27 | 2.67 | ||||
HSIC | 9.4B | 12.3B | 22.59 | 0.76 | ||||
BIO | 8.1B | 2.7B | -12.64 | 3.01 | ||||
XRAY | 6.3B | 4.0B | -47.15 | 1.6 | ||||
AXNX | 3.4B | 366.4M | -560.12 | 9.28 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.95 | 0.41 | ||||
ANIK | 379.4M | 166.7M | -4.59 | 2.28 | ||||
ANGO | 232.3M | 324.0M | -1.21 | 0.72 | ||||
APYX | 49.9M | 52.3M | -2.67 | 0.95 | ||||
AEMD | 3.6M | 3.7M | -0.29 | 0.95 |
BioSig Technologies Inc News
Income Statement (Quarterly) | |||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 |
Revenue | 1100.0% | 12,000 | 1,000 | 45,667 | 90,333 | 135,000 | 135,000 | 8,000 | 8,000 | 8,000 | 108,000 | 207,000 | 118,000 |
Cost Of Revenue | - | - | - | - | - | - | - | - | - | - | 38,000 | 62,000 | 99,000 |
Gross Profit | 1100.0% | 12,000 | 1,000 | - | - | 108,000 | 105,000 | 8,000 | 8,000 | 8,000 | 70,000 | 145,000 | 19,000 |
Operating Expenses | 52.5% | 6,179,000 | 4,052,000 | 10,908,000 | 7,391,000 | 7,106,000 | 6,591,000 | 5,724,000 | 8,073,000 | 9,007,000 | 7,871,000 | 8,196,000 | 8,579,000 |
S&GA Expenses | -100.0% | - | 2,815,000 | 9,107,000 | 6,245,000 | 5,903,000 | 4,774,000 | 4,302,000 | 6,401,000 | 7,597,000 | 6,505,000 | 6,480,000 | 7,271,000 |
R&D Expenses | 10.4% | 1,214,500 | 1,100,000 | 1,709,000 | 1,062,000 | 1,121,000 | 1,700,000 | 1,400,000 | 1,600,000 | 1,350,000 | 1,300,000 | 1,700,000 | 1,300,000 |
EBITDA Margin | -358.0% | -1,573 | -343 | -208 | -119 | -94.29 | -89.29 | -81.96 | -79.93 | -74.05 | - | - | - |
Interest Expenses | 0% | 1,000 | 1,000 | 3,000 | 4,000 | 2,000 | 1,000 | - | - | - | 1,000 | - | 1,000 |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | -51.3% | -6,128,000 | -4,050,000 | -11,130,000 | -7,382,000 | -6,996,000 | -6,485,000 | -5,716,000 | -8,065,000 | -8,999,000 | -7,247,000 | -8,051,000 | -8,559,000 |
EBT Margin | -358.4% | -1,593 | -347 | -210 | -121 | -95.32 | -90.12 | -82.61 | -80.45 | -74.50 | - | - | - |
Net Income | -23.8% | -5,654,500 | -4,567,000 | -11,130,000 | -7,382,000 | -6,928,500 | -6,372,000 | -5,716,000 | -8,065,000 | -8,349,000 | -7,253,000 | -8,051,000 | -8,559,000 |
Net Income Margin | -352.2% | -1,596 | -353 | -209 | -120 | -94.69 | -87.77 | -80.83 | -78.85 | -73.04 | - | - | - |
Free Cashflow | 25.9% | -2,904,000 | -3,917,000 | -4,972,000 | -5,693,000 | -4,172,000 | -4,997,000 | -6,708,000 | -5,996,000 | -5,875,000 | -6,974,000 | -6,971,000 | -7,121,000 |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -43.0% | 1,798 | 3,154 | 4,050 | 5,197 | 4,110 | 5,015 | 9,590 | 4,110 | 15,519 | 21,673 | 18,027 | 24,516 | 30,386 | 34,953 | 39,812 | 17,841 | 14,217 | 14,221 | 12,062 | 11,904 | 4,997 |
Current Assets | -49.8% | 528 | 1,051 | 1,987 | 2,150 | 1,128 | 3,089 | 7,736 | 11,002 | 13,894 | 19,999 | 16,949 | 23,334 | 29,337 | 33,893 | 38,652 | 16,560 | 12,828 | 12,883 | 10,640 | 11,090 | 4,629 |
Cash Equivalents | -51.2% | 190 | 389 | 1,252 | 1,412 | 357 | 887 | 5,077 | 8,665 | 11,659 | 17,535 | 15,504 | 22,475 | 28,268 | 32,748 | 36,927 | 15,500 | 12,109 | 12,309 | 10,334 | 10,934 | 4,450 |
Inventory | -100.0% | - | 219 | 189 | 345 | 336 | 1,691 | 2,026 | 2,026 | 1,881 | 1,881 | 731 | 650 | 768 | 806 | 800 | 800 | 600 | - | - | - | - |
Net PPE | -14.2% | 509 | 593 | 621 | 630 | 665 | 685 | 596 | 656 | 652 | 557 | 388 | 381 | 289 | 188 | 175 | 185 | 180 | 102 | 78.00 | 180 | 44.00 |
Liabilities | 14.2% | 4,685 | 4,104 | 3,614 | 3,182 | 3,713 | 3,076 | 2,508 | 3,027 | 2,954 | 2,993 | 3,405 | 3,953 | 5,109 | - | - | - | - | 1,589 | 1,882 | 1,236 | 1,198 |
Current Liabilities | 17.2% | 4,582 | 3,911 | 3,332 | 2,814 | 3,261 | 2,540 | 1,899 | 2,709 | 2,576 | 2,571 | 3,383 | 3,896 | 5,108 | 4,960 | 3,607 | 1,584 | 2,030 | 1,213 | 1,414 | 1,009 | 1,198 |
Shareholder's Equity | -Infinity% | -2,992 | - | 331 | 1,910 | 313 | 1,834 | 6,977 | 9,410 | 12,460 | 18,575 | 14,517 | 20,458 | 25,172 | 29,866 | 36,012 | 15,851 | 11,661 | 12,418 | 9,965 | 10,193 | 3,324 |
Retained Earnings | -2.5% | -245,015 | -238,966 | -234,399 | -223,306 | -215,974 | -209,016 | -202,644 | -196,885 | -188,922 | -180,278 | -173,025 | -165,324 | -157,005 | -146,712 | -135,310 | -116,122 | -104,787 | -89,994 | -84,551 | -76,601 | -70,731 |
Additional Paid-In Capital | 1.8% | 241,988 | 237,727 | 234,568 | 225,215 | 216,232 | 210,792 | 209,456 | 206,240 | 201,127 | 198,380 | 187,136 | 185,168 | 181,344 | 175,228 | 168,499 | 131,340 | 115,910 | 101,484 | 94,495 | 86,466 | 74,039 |
Shares Outstanding | 14.1% | 9,040 | 7,924 | 7,346 | 6,686 | 5,461 | 4,031 | 4,481 | 3,956 | 3,557 | 3,525 | 3,221 | 3,211 | - | - | - | - | - | - | - | - | - |
Minority Interest | -75.2% | 26.00 | 105 | 89.00 | -66.00 | -21.00 | 12.00 | 120 | 16.00 | 219 | 438 | 374 | 582 | 802 | 1,320 | 2,794 | 607 | 515 | 406 | - | - | - |
Float | - | - | - | 76,956 | - | - | - | 28,094 | - | - | - | 108,511 | - | - | - | 182,303 | - | - | - | 146,426 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 24.8% | -2,900 | -3,857 | -4,895 | -5,648 | -4,114 | -4,947 | -6,703 | -5,941 | -5,731 | -6,758 | -6,919 | -6,991 | -6,104 | -6,274 | -8,281 | -5,942 | -3,901 | -3,939 | -4,119 | -3,522 | -2,969 |
Share Based Compensation | 100.0% | - | -359 | 4,742 | 2,149 | 1,709 | 537 | 166 | 2,000 | 4,597 | 63.00 | 611 | 2,519 | -1,859 | 175 | 429 | 4,413 | - | - | 477 | 2,670 | 4,208 |
Cashflow From Investing | 93.3% | -4.00 | -60.00 | -77.00 | -45.00 | -58.00 | -50.00 | -5.00 | -55.00 | -144 | -216 | -52.00 | -130 | -27.00 | -32.00 | -8.00 | -20.00 | -90.11 | -38.06 | -83.81 | -73.02 | -57.31 |
Cashflow From Financing | -9.2% | 2,747 | 3,025 | 4,812 | 6,748 | 3,642 | 807 | 3,120 | 3,002 | -1.00 | 9,005 | - | 1,328 | 1,650 | 2,127 | 29,716 | 9,354 | 3,792 | 5,952 | 3,604 | 10,079 | 197 |
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Revenue: | ||
Total revenue | $ 18 | $ 286 |
Cost of revenue | 57 | |
Gross profit | 18 | 229 |
Operating expenses: | ||
Research and development | 5,092 | 5,821 |
General and administrative | 23,077 | 21,380 |
Depreciation and amortization | 361 | 293 |
Total operating expenses | 28,530 | 27,494 |
Loss from operations | (28,512) | (27,265) |
Other income (expense): | ||
Interest income, net | 9 | 3 |
Other income (expense), net: | (187) | |
Loss before income taxes | (28,690) | (27,262) |
Income taxes (benefit) | ||
Net loss | (28,690) | (27,262) |
Non-controlling interest | (351) | 210 |
Net loss attributable to BioSig Technologies, Inc. | (29,041) | (27,052) |
Preferred stock dividend | (9) | (9) |
Preferred stock deemed dividend | (210) | |
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS | $ (29,050) | $ (27,271) |
Net loss per common share, basic | $ (3.95) | $ (6.33) |
Net loss per common share, diluted | $ (3.95) | $ (6.33) |
Weighted average number of common shares outstanding, basic | 7,351,794 | 4,307,244 |
Weighted average number of common shares outstanding, diluted | 7,351,794 | 4,307,244 |
Product [Member] | ||
Revenue: | ||
Total revenue | $ 254 | |
Service [Member] | ||
Revenue: | ||
Total revenue | $ 18 | $ 32 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash | $ 190 | $ 357 |
Accounts receivable | 24 | 9 |
Employee advance | 5 | |
Inventory, short term | 336 | |
Net investment in leases, short term | 103 | 101 |
Prepaid expenses and vendor deposits | 206 | 325 |
Total current assets | 528 | 1,128 |
Property and equipment, net | 509 | 665 |
Right-to-use assets, net | 412 | 705 |
Other assets: | ||
Inventory, long term | 1,141 | |
Net investment in leases, long term | 17 | 120 |
Patents, net | 288 | 307 |
Other assets | 44 | 44 |
Total assets | 1,798 | 4,110 |
Current liabilities: | ||
Accounts payable and accrued expenses, including $30 and $120 to related parties as of December 31, 2023 and 2022, respectively | 4,116 | 2,852 |
Customer deposits | 16 | |
Deferred revenue, short term | 5 | |
Dividends payable | 101 | 91 |
Lease liability, short term | 349 | 313 |
Total current liabilities | 4,582 | 3,261 |
Lease liability, long term | 103 | 452 |
Total long-term liabilities | 103 | 452 |
Total liabilities | 4,685 | 3,713 |
Commitments and contingencies (Note 12) | ||
Series C 9% Convertible Preferred Stock, $0.001 par value, $1,000 stated value, authorized 4,200 shares, 105 shares issued and outstanding; liquidation preference of $105 as of December 31, 2023 and 2022 | 105 | 105 |
Equity (Deficit): | ||
Preferred stock, $0.001 par value, authorized 1,000,000 shares, designated 200 shares of Series A, 600 shares of Series B, 4,200 shares of Series C, 1,400 shares of Series D, 1,000 shares of Series E, 200,000 shares of Series F Preferred Stock. 105 shares of Series C outstanding as of December 31, 2023 and 2022 (see above) | ||
Common stock, $0.001 par value, authorized 200,000,000 shares, 9,040,043 and 5,505,068 issued and outstanding as of December 31, 2023 and 2022, respectively | 9 | 5 |
Additional paid in capital | 241,988 | 216,282 |
Accumulated deficit | (245,015) | (215,974) |
Total stockholders’ equity (deficit) attributable to BioSig Technologies, Inc. | (3,018) | 313 |
Non-controlling interest | 26 | (21) |
Total equity (deficit) | (2,992) | 292 |
Total liabilities and equity (deficit) | $ 1,798 | $ 4,110 |